Long-acting insulin analog

This page covers all Long-acting insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (1)

• Insulin glargine (LANTUS) · Sanofi · Diabetes
  Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels.

Phase 3 pipeline (1)

• Insulin Aspart 6 Day (6D) · Eli Lilly and Company · Diabetes
  Insulin Aspart 6 Day is a long-acting basal insulin analog designed to provide extended glucose control with a 6-day duration of action.